key: cord-0870954-jjnh72vu authors: Finsterer, Josef title: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials date: 2021-11-15 journal: Ann Clin Transl Neurol DOI: 10.1002/acn3.51469 sha: bc7d0b83e3a7f4fc9fa31cd1994133b7c2901f4c doc_id: 870954 cord_uid: jjnh72vu nan With interest we read the article by Kania et al. about a 19-year female diagnosed with SARS-CoV-2 vaccination-triggered acute, disseminated, encephalomyelitis (ADEM) upon clinical presentation (headache, fever, neck/back pain, nausea, vomiting, and urinary retention), cerebral and spinal magnetic resonance imaging (MRI) findings (multiple, poorly demarcated, hyperintense lesions on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images located in both hemispheres, pons, medulla oblongata, and cerebellum, which partially enhanced), and cerebro-spinal fluid (CSF) investigations (pleocytosis of 294/3, elevated protein). 1 Two weeks prior to presentation she had undergone a first vaccination with an mRNA-based SARS-CoiV-2 vaccine (Moderna). 1 She partially recovered under methyl-prednisolone. 1 The study is appealing but raises concerns and comments. We do not agree that ADEM may be only due to viral infections or vaccinations. 1 ADEM has been also reported following radio-chemotherapy, 2 bacterial infections with E. coli, 3 synthetic cannabinoids, 4 viper venoms, 5 herbal extracts, 6 hyponatriemia, or genetic disease, such as Xlined Charcot Marie Tooth disease due to GJB1 mutations. 7 Differential diagnoses were not appropriately excluded. We should know if immune encephalitis was excluded by determination of specific antibodies associated with immune encephalitis, such as NMDA, AMPAR, LGI1, NLBP12, etc. 8 We should know if multifocal PRES due to porphyria had been excluded. 9 Was the patient ever tested for SARS-CoV-2? The vaccination can be ineffective. We should know for how long the patient had received ceftriaxone and acyclovir. Is it conceivable that the patient did not actually profit from steroids but rather from the antibiotic or the antiviral medication? How can the authors be sure that ADEM was due to the vaccination and not due to a viral agent, remaining undetected in the CSF? Oligoclonal bands were negative in the index patient suggesting that the condition was not immunogenic but rather infectious. We should be informed if the CSF was tested for RNA of SARS-CoV-2. The CSF had been previously shown to be positive for virus RNA in single patients. 10 However, most previous studies on SARS-CoV-2 infection associated ADEM have shown that the CSF was negative for virus RNA. 11 We should be informed if the intra-thecal IgG production was elevated or not. We should be informed about the imaging findings using imaging modalities other than T2/FLAIR. Overall, the elegant study has several limitations, which challenge the results and their interpretation. Infectious agents need to be more thoroughly excluded. Differentials of ADEM need to be more widely considered. More details about imaging findings should be provided. Informed consent was obtained. The study was approved by the institutional review board. The authors declare no conflict of interest. JF was involved in design, literature search, discussion, first draft, and critical comments. Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2 Acute disseminated encephalomyelitis following chemoradiotherapy in an adult patient with nasopharyngeal cancer An interesting case of acute disseminated encephalomyelitis following E. coli infection Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of synthetic cannabinoid black mamba Case report: acute demyelinating encephalomyelitis following viper bite acute disseminated encephalomyelitis after oral therapy with herbal extracts: a case report X-linked Charcot-Marie-Tooth disease with GJB1 mutation presenting as acute disseminated encephalomyelitis-like illness: a case report Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome Posterior reversible encephalopathy syndrome in a patient with variegate porphyria: a case report Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development Two paediatric patients with encephalopathy and concurrent COVID-19 infection: two sides of the same coin? The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of